Passer au contenu principal

sulfatase modifying factor 1

La SUMF1 gene provides instructions for making an enzyme called formylglycine-generating enzyme (FGE). This enzyme is found in a cell structure called the endoplasmic reticulum, which is involved in protein processing and transport. The FGE enzyme modifies other enzymes called sulfatases, which aid in breaking down substances that contain chemical groups known as sulfates. These substances include a variety of sugars, fats, and hormones. Specifically, FGE converts a protein building block (amino acid) within sulfatases called cysteine into a molecule called C-alpha-formylglycine.

Sélections vidéo pour Gènes
Bibliothèque vidéo

Normal function

La SUMF1 gene provides instructions for making an enzyme called formylglycine-generating enzyme (FGE). This enzyme is found in a cell structure called the endoplasmic reticulum, which is involved in protein processing and transport. The FGE enzyme modifies other enzymes called sulfatases, which aid in breaking down substances that contain chemical groups known as sulfates. These substances include a variety of sugars, fats, and hormones. Specifically, FGE converts a protein building block (amino acid) within sulfatases called cysteine into a molecule called C-alpha-formylglycine.

Conditions referring to this gene or chromosome

Other names

AAPA3037

C-alpha-formylglycine-generating enzyme 1

FGE

FGly-generating enzyme

sulfatase-modifying factor 1

UNQ3037

Related patient information and medicines

Médicaments antirhumatismaux modificateurs de la maladie

Patient information leaflet

Médicaments antirhumatismaux modificateurs de la maladie

Médicaments antirhumatismaux modificateurs de la maladie (DMARDs) are medicines that are normally prescribed as soon as rheumatoid l'arthrite (RA) is diagnosed, in order to reduce damage to the joints. Médicaments antirhumatismaux modificateurs de la maladie (DMARDs) are a group of medicines that are used to ease the des symptômes de arthrite rhumatoïde (RA) Rheumatoid l'arthrite and reduce.

Arthrite réactive

Patient information leaflet

Arthrite réactive

... If symptoms continue for more than a few months, or if other treatments have not worked, you may be advised to take a disease-modifying medicine Disease-modifying antirheumatic drugs. These are sometimes called disease-modifying antirheumatic drugs (DMARDs). This aims to reduce the damaging effect on the joints. There are several - for.

Arthrite psoriasique

Patient information leaflet

Arthrite psoriasique

Arthrite psoriasique is a particular type de l'arthrite that develops in some people who also have psoriasis. Arthritis Arthritis means inflammation of the joints. They work by blocking the effects of chemicals involved in causing joint inflammation. Sulfasalazine Sulfasalazine and methotrexate Methotrexate are the most commonly used DMARDs for.

Polyarthrite rhumatoïde

Patient information leaflet

Polyarthrite rhumatoïde

Rheumatoid arthritis causes inflammation, pain, and swelling of joints. Rheumatoid l'arthrite treatment Standards of care vous should expect The National Institute for Health and Care Excellence (NICE) has published quality standards on the standard of care that should be offered to every adult over 16 who has RA. ...Ds) Disease-modifyingDMARDs.

Cholangite sclérosante primitive

Patient information leaflet

Cholangite sclérosante primitive

Primaire sclerosing cholangitis is an uncommon condition affecting the bile ducts and liver. Inflammation and scarring of the bile ducts can lead to liver damage and cirrhosis - a condition where normal liver tissue is replaced by scar tissue (fibrosis). Different treatments are available to control symptoms that may develop and also to manage ....

Arthrite juvénile idiopathique

Patient information leaflet

Arthrite juvénile idiopathique

So, juvenile idiopathic arthritis (JIA) is a condition in which this inflammation of one or more joints begins in children under the age of 16 years. ...e used to help reduce the effects of the disease Disease-modifyingDMARDs used for JIA include: Methotrexate Methotrexate Sulfasalazine Sulfasalazine Leflunomide Leflunomide tablets for arthritis.

Lectures complémentaires et références

Historique de l'article

Les informations sur cette page sont rédigées et examinées par des cliniciens qualifiés.
  • 18 Aug 2020 | Dernière version
  • 1 Jul 2014 | Publié à l'origine

Participez à la conversation

Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.

Avertissement : The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Pharmacie en ligne, traitements et services de santé

Accès simple à des traitements fiables et à des services de santé en ligne.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Inscrivez-vous à la newsletter Patient

Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.

Veuillez entrer une adresse e-mail valide

En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.